Merger to consolidate company’s global footprint
After months of deliberation and formalities which began in 2019, the merger of agri-business major SynTech Research, USA and the European Contract Research Organization (CRO) major Acceres, has now successfully met all the requirements to form a world-leading global Agricultural R&D CRO. Consisting of Acceres, (which includes Biotek Agriculture, GAB Consulting and Promovert) and SynTech Research, the new company will be a leading global player in this sector, with over 600 laboratory, field and regulatory staff providing services in over forty countries, in all Regions.
Dr Khosro Khodayari has been appointed as CEO of the new Company, chairing the Global Executive Committee (GEC), leading further integration activities and serving on the Board of Directors (BoD). Dr Francis Lacroze, former SGS, who has been involved with EKKIO Capital in the development of Acceres, has been appointed as Chairman of the BoD. EKKIO Capital are the majority shareholders and will provide the additional investment required for rapid growth of the new Company through acquisitions and Greenfield expansion projects. As previously announced, once integration activities have been completed, the name of the new Company will be formalized as SynTech Research.
SynTech Research which was founded in California 1999 had initially focused on field GLP and bio-efficacy in the US. The company started work in India in 2010 and was the first Contract Research Organisation (CRO) in the country. It works in partnership with a local CRO to deliver client’s trials programs. Currently trials on agrochemicals and new plant varieties including bio-safety research level (BRL) GMO trials are being carried out in several locations in Andhra Pradesh, Karnataka, Tamil Nadu, Maharastra, Punjab and Uttar Pradesh.
